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Abstract 
 Objectives: This Study was designed to investigate the role of the auto antibodies 
against  thyroid peroxidise (TPO-Abs) and thyroid Hormones (T3, T4, TSH)  in pathogenesis 
of Autoimmune Thyroid Disease (AITD). 
Methodology: Blood parameters of (90) individual  who were attended to hormonal centre at 
AlSadder Medical City, in the period from January 2013 to June 2013 were measured, which 
includes Ttriiodothyronine (T3), Thyroxine or Tetraiodothyronine (T4), Thyroid Stimulating 
Hormone (TSH) and auto antibodies  of thyroid peroxidise (TPO-Abs), the biostatic use 
difference between the maximum and minimum values (range). 
Results: the search results showed no significant increase in the rate of thyroid hormones 
(T3, T4, TSH) (p>0.2). 
Conclusion: The auto antibodies  of thyroid peroxidise has no rule in function of thyroid 
hormones. 
 
Keywords: Autoimmune Thyroid Disease (AITD), thyroid hormones (T3, T4, TSH), anti-
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Introduction 
 Autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and 
Hashimoto's thyroiditis (HT), are caused by immune response to self-thyroid antigens and 
affect approximately (2–5%) of the general population. Genetic susceptibility in combination 
with external factors, such as smoking, viral/bacterial infection, and chemicals, is believed to 
initiate the autoimmune response against thyroid antigens (1).Autoantibodies to thyroid 
peroxidase (TPO) are reflections of thyroid disease rather than causative agents . Hence, such 
thyroid autoantibodies may develop before the onset of clinical (AITD) and have been long 
known to increase the risk of developing clinical (AITD). Indeed, up to (50%) of the siblings 
of patients with (AITD) are thyroid antibody positive in contrast to (~15%) in the general 
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population(2) .Thyroxine ( T4 ) and triiodothyronine ( T3 ) are vital for normal growth and 
development and control essential functions , such as energy, metabolism and protein 
synthesis  while reverse triiodothyronine ( rT3 ) is inactive hormone(3). TSH (Thyroid 
Stimulating Hormone) is also known as thyrotropin. which increases thyroid secretion(4). The 
secretion of TSH is controlled by: 
- Circulating concentration of thyroid hormones. 
- Thyrotrophin-Relasing Hormones (TRH)(5). 
 The metabolic manifestations of the thyroid disease related to either excessive or 
inadequate production of thyroid hormones (hyperthyroidism and hypothyroidism, 
respectively)(6). 
 Blood tests: Usually includes measurement of: serum T4 and T3, resin T3 uptake, T4 
binding ratio, free T4 index, TSH, and antithyroid antibodies level(7). 
 
Objectives 
Perverse study was performed on (90) individual who were attended to AlSadder 
Medical City, in the period from January 2013 to June 2013.Three study groups were 
investigated which included:  First group: Thirty patients with Hypothyroidism  of both sexes 
(26 female and 4 male)  their ages>15 years old. Second group: Thirty patients with 
Hyperthyroidism of both sexes (20 female and 10 male)  their ages >15 years old. Third 
group: Thirty people as a control group who had no history or clinical evidence of  any acute 
and chronic disease. All samplewere kept for few minutes to allow the clotting form. Serum 
was separated by centrifugation at (1500) rpm and divided into small (200 μl ) aliquots and 
kept at deep freeze (-20 C˚) to be used for different investigations by us ELISA technique. 
 
Results 
The result of this study consist of (90) patients, (30) of them having Hashimotos 
disease and (30) of them Graves disease and (30) controls. The patients enrolled in this study 
were males and females. They were typical of patients suffering from AITD.  
 Table (1) showed that there were no significant correlation between anti-TPO-Ab and 
Thyroid hormones (T3,T4, and TSH)(p=0.954, 0.914, 0.379 respectively ) in HT patients. 
 Table (2) showed that there were no significant correlation between anti-TPO-Ab and 
Thyroid hormones (T3,T4, and TSH)(p=0.947, 0.790, 0.790 respectively ) in GD patients. 
 Table (3) showed that there were no significant correlation between anti-TPO-Ab and 
Thyroid hormones (T3,T4, and TSH)(p=0.233, 0.224, 0.204 respectively ) among control 
group. 
Table(1) Correlation between Anti-Thyroidal peroxidase A band Thyroid hormones (T3,T4, and TSH) among 
HT patients. 
 
Table(2) Correlation between Anti-Thyroidal  peroxidise antibodies and Thyroid hormones (T3,T4, and TSH) 
among GD patients. 
 
 
 Anti-TPO-antibodies 
Hormones Rang P value 
T3 0.011 0.954 
T4 0.021 0.914 
TSH -0.045 0.379 
 Anti-TPO-antibodies 
Hormones Rang P value 
T3 -0.013 0.947 
T4 0.051 0.790 
TSH 0.232 0.218 
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Table(3) Relation between Anti-Thyroidal peroxidase Ab and Thyroid hormones (T3,T4, and TSH),  among 
control group. 
 
Discussion 
In recent years, the pathogenic role and the diagnostic value of anti-TPO antibody 
have been evaluated in (AITD) patients. Most of studies show detection of anti-TPO antibody 
has high specificity for (AITD) and the presence of anti-TPO antibody has been noted in 
early (AITD)(9). Their mean age distribution were in agreement with many studies that have 
been done before (8). 
Moreover, (10) shows the appearance of anti-TPO antibody in the circulation may 
occur at several years before (AITD) onset and anti-TPO antibody represents a marker of 
future (AITD). The importance of anti-TPO evokes in diagnosis of (AITD). However, present 
data represented these no relationships between anti-TPOantibodies and Thyroid hormones 
(T3,T4, and TSH ). Thesefindings were compatible to the results reported by (11) who found 
that proportional correlation was noticed between anti-TPO and (AITD) marker particularly 
TSH. The normal levels of T3 is below 1.6 nm/l and for T4 is between (4.2-11.0 nm/l) 
,while,the normal levels of TSH is 0.25 to 5 (12) . Serum TSH concentration are considered the 
most reliable indicator of thyroid function abnormalities, and TSH analysis stands as the 
primary means of study thyroid function.However, small changes in T4 concentration will 
provoke very large changes in serum TSH (13). Because the pathogenesis of (AITD). 
It is still not well clear, many studies in relation with it. Therefore, in this study we 
have analyzed and examined the role of an increase of anti-TPO-Ab serum level in function 
of thyroid hormones. However, the current findings concerning there was any increase in T3, 
T4 and TSH serum levels depending on concentration of anti-TPO-Ab. However, These 
findings were compatible to the results reported by (14) who found that strong correlation was 
noticed between anti-TPO and AITD marker particularly TSH. Our study was 
correspondence with previous studies (15) they mentioned ,there areno relationship between 
Serum TSH concentration and anti-TPO-Ab also no association between thyroid hormones 
(T3, T4) and anti-TPO-Ab. This was expected (16). 
 
Conclusion 
 There are no relationship between Serum (T3, T4, and TSH ) concentration and anti-
TPO-antibodies. Anti-Thyroid Peroxidase Antibodies (IgG) a good serological marker for 
diagnosis of  (AITD) and to be used routinely. More than one diagnostic test is required for  
such diseases .  
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